In the transgenic MMTV-ERBB2/neu mouse model, 30 days of TMI-1 treatment has been described to reduce tumor growth [47], but Tardáguila described a downregulation of CX3CL1 in the tumors of these mice compared to the healthy tissue. This evidence concerns the gene CX3CL1 and neoplasm.